• ZIerhut Manfred
  • Sobolewska Bianka
Living reference work entry


A 4-year-old girl presented with oligoarticular juvenile idiopathic arthritis-associated bilateral nongranulomatous uveitis. The onset of arthritis preceded uveitis. In spite of immunosuppressive treatment in combination with anti-TNF-α agents, she developed cataract and band keratopathy as a result of the continuing chronic course of uveitis.


Juvenile Idiopathic Arthritis Kawasaki Disease Macular Edema Lyme Disease Anterior Uveitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. Abu Samra K, Maqhsoudlou A, Roohipoor R, Valdes-Navarro M, Lee S, Foster CS. Current treatment modalities of JIA-associated uveitis and its complications: literature review. Ocul Immunol Inflamm. 2016;14:1–9.CrossRefGoogle Scholar
  2. Clarke SL, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2016;14:27.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Januschowski K, Voykov B, Deuter C. Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol. 2014;98:523–8.CrossRefPubMedGoogle Scholar
  4. Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology. 2001;108:2071–5.CrossRefPubMedGoogle Scholar
  5. Tugal-Tutkun I, Quartier P, Bodaghi B. Juvenile idiopathic arthritis-associated uveitis-classification and diagnostic approach. Ocul Immunol Inflamm. 2014;22:56–63.CrossRefPubMedGoogle Scholar
  6. Vastert SJ, Bhat P, Goldstein DA. Pathophysiology of JIA-associated Uveitis. Ocul Immunol Inflamm. 2014;22:414–23.CrossRefPubMedGoogle Scholar
  7. Vitale AT, Graham E, De Boer JH. Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome. Ocul Immunol Inlfamm. 2013;21:478–85.CrossRefGoogle Scholar

Copyright information

© Springer (India) Pvt. Ltd. 2016

Authors and Affiliations

  1. 1.Centre for OphthalmologyUniversity Eye Hospital, Eberhard-Karls UniversityTuebingenGermany

Personalised recommendations